Björklund Pharma

Advancing healthcare and wellness

  • Home
  • Company
  • Pipeline
  • Ventures
  • Publications
  • Media
  • Contact

Ventures

Björklund Pharma strategically invests in and operates healthcare ventures, including specialized clinical services. With a strong commitment to scientific innovation and patient-centered care, the company balances direct ownership of key strategic investments alongside minority stakes that complement its product development efforts.


Updated 2025-07-17

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Company News

  • New COVID-19 Research Provides Insights on the Crucial Role of Zinc in Protein Targets of Drugs That Block SARS-CoV-2 Infection
  • A Possible New Medicine for Multiple Sclerosis?
  • Thymosin Beta 4 in Dry Eye Syndrome
  • The Role of Thymosin Beta 4 in COVID-19 Treatment

Contact Us

Björklund Pharma AS
Toften 24
8610 Mo i Rana
Norway

Phone: +47 411 11 942
Email: info(at)bjorklundpharma.com

Copyright © 2025 Björklund Pharma AS